Immune Checkpoint Inhibitor-Related Autoimmune Pancreatitis-Risk Factors and Outcomes

被引:0
|
作者
Nuguru, Shashank [1 ,3 ,4 ]
Manne, Ashish [2 ,3 ]
机构
[1] Augusta Univ, Dept Med, Med Coll Georgia, Augusta, GA USA
[2] Ohio State Univ, Arthur G James Canc Hosp, Comprehens Canc Ctr, Div Med Oncol, Columbus, OH USA
[3] Ohio State Univ, Comprehens Canc Ctr, Richard J Solove Res Inst, 1300K Lincoln Tower,1800 Canon Dr, Columbus, OH 43210 USA
[4] Ohio State Univ, Arthur G James Canc Hosp, Dept Internal Med, Div Med Oncol,Comprehens Canc Ctr, 1300K Lincoln Tower, 1800 Canon Dr, Columbus, OH 43210 USA
来源
GASTRO HEP ADVANCES | 2024年 / 3卷 / 03期
关键词
D O I
10.1016/j.gastha.2024.03.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:440 / 441
页数:2
相关论文
共 50 条
  • [34] ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
    Horiguchi, Haruki
    Kadomatsu, Tsuyoshi
    Yamashita, Tomoya
    Yumoto, Shinsei
    Terada, Kazutoyo
    Sato, Michio
    Morinaga, Jun
    Miyata, Keishi
    Oike, Yuichi
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [35] Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion
    Kramer, Sjoerd
    van Hee, Koen
    Blokzijl, Hans
    van der Heide, Frans
    Visschedijk, Marijn C. C.
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (07) : 271 - 275
  • [36] ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
    Haruki Horiguchi
    Tsuyoshi Kadomatsu
    Tomoya Yamashita
    Shinsei Yumoto
    Kazutoyo Terada
    Michio Sato
    Jun Morinaga
    Keishi Miyata
    Yuichi Oike
    Communications Biology, 6
  • [37] Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related Esophagitis
    Panneerselvam, Kavea
    Amin, Rajan N.
    Wei, Dongguang
    Tan, Dongfeng
    Lum, Phillip J.
    Zhang, Hao Chi
    Richards, David M.
    Altan, Mehmet
    Grivas, Petros
    Thompson, John A.
    Thomas, Anusha S.
    Wang, Yinghong
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (08): : 896 - 904
  • [38] Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related Esophagitis
    Panneerselvam, Kavea
    Amin, Rajan
    Wei, Dongguang
    Tan, Dongfeng
    Lum, Phillip
    Zhang, Hao Chi
    Richards, David
    Altan, Mehmet
    Grivas, Petros
    Thompson, John
    Thomas, Anusha Shirwaikar
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S226 - S227
  • [39] Risk factors for immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer
    Chao, Yencheng
    Zhou, Jiebai
    Hsu, Shujung
    Ding, Ning
    Li, Jiamin
    Zhang, Yong
    Xu, Xiaobo
    Tang, Xinjun
    Wei, Tianchang
    Zhu, Zhengfei
    Chu, Qian
    Neal, Joel W.
    Wu, Julie Tsu-Yu
    Song, Yuanlin
    Hu, Jie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (02) : 295 - +
  • [40] Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
    Rilan Bai
    Naifei Chen
    Xiao Chen
    Lingyu Li
    Wei Song
    Wei Li
    Yuguang Zhao
    Yongfei Zhang
    Fujun Han
    Zheng Lyu
    Jiuwei Cui
    Cancer Biology & Medicine , 2021, (04) : 1118 - 1133